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In 1981, researchers working 
independently on two continents 
ushered in a new era of biomedicine by 
isolating stem cells from early mouse 
embryos and sustaining the famously 
finicky cells in Petri dishes. These 
cultured “pluripotent” cells, which can 
generate any of the 200-plus cell types 
in the body, looked and behaved like 
normal embryo cells, giving researchers 
a powerful model for understanding 
development and disease. But efforts 
to develop similar tools working 
with human embryonic stem (ES) 
cells stalled when ethical and legal 
restrictions on human embryos and 
embryonic cell lines hamstrung a field 
still in its infancy. 
The future looked brighter in 
2007, when teams of scientists, again 
working independently, reported a way 
to produce human ES cells without 
eggs. The technique, demonstrated in 
mice in 2006, reset the developmental 
clock of adult human skin cells back 
into an embryonic state, freed of their 
epithelial obligations and receptive 
to an entirely different fate. Infecting 
human skin cells (or mouse embryonic 
fibroblasts, MEFs, in the 2006 study) 
with retroviral vectors carrying four 
reprogramming genes—Oct3/4, Sox2,
Klf4, and c-Myc—generated induced 
pluripotent stem (iPS) cells that appear 
indistinguishable from ES cells in terms 
of morphology, cell surface markers, 
proliferative capacity, gene expression, 
and methylation state. (Stem cells have 
different  “epigenetic” modifications 
such as methylation, the addition 
of methyl groups to DNA, than 
differentiated cells do, allowing them 
to keep their developmental options 
open.) Only about 0.01% of the adult 
cells became iPS cells, however, and the 
origin of these cells was unknown. 
Now, Jose Silva, Austin Smith, and 
colleagues report that iPS cells can be 
generated faster and more efficiently by 
genetically reprogramming stem cells 
derived from tissue. The researchers 
suspected that tissue-derived stem 
cells might have fewer epigenetic 
restrictions and thus respond better 
to reprogramming signals than other 
cells. Previous work showed that neural 
stem (NS) cells can be efficiently 
converted into pluripotent cells 
using two common reprogramming 
techniques (fusion with ES cells and 
transfer of nuclear material into eggs 
cells). The researchers wondered 
whether NS cells extracted from mouse 
brains would respond similarly to iPS. 
To reprogram body (somatic) cells 
into iPS cells, researchers first isolate 
and culture cells, then use a retrovirus 
to introduce the reprogramming 
genes into the cells. Typically, 
reprogramming involves repeating this 
step several times to yield rare cells 
that undergo reprogramming through 
apparently random processes. Silva et 
al. hoped that by using tissue-derived 
cells and identifying optimal conditions 
for reprogramming, they could 
generate far more iPS cells in less time.
First, they infected MEFs with 
retroviral vectors carrying the 
reprogramming factors Oct4, Sox2,
Klf4, and c-Myc, following the 
protocol described in the 2006 study. 
Consistent with previous reports, the 
cells reached an undifferentiated 
state after three weeks, based on 
appearance and expression of an Oct4
reporter transgene, which appears as 
the cell takes over Oct4 expression 
from the retrovirus. When the 
researchers infected NS cells with the 
reprogramming vectors, they found 
a surprisingly high percentage had 
acquired the characteristic appearance 
and surface markers of ES cells (Fgf4, 
Rex1, Nanog, and endogenous Oct4), 
though at lower levels. The converted 
cells did not qualify as pluripotent, 
however, because their X chromosomes 
remained inactive. (In differentiated 
cells, epigenetic marks silence one X 
chromosome in female cells, so females 
don’t produce twice as many X-linked 
gene products as males.).
The pluripotency of ES cells can 
be maintained indefinitely by using a 
chemical cocktail designed to inhibit 
differentiation signals. The researchers 
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Immunofluorescence staining for two indicators of pluripotency,  trimethyl H3K27 and 
Nanog, in cells that had undergone induced pluripotent stem cell reprogramming.PLoS Biology  |  www.plosbiology.org 2077 October 2008  |  Volume 6  |  Issue 10  |  e275
wondered whether these conditions 
could jumpstart the resetting process 
in the partially reprogrammed cells. 
They used a culture medium spiked 
with two small molecule inhibitors 
(2i) and bathed the cells with a factor 
(LIF) known to maximize ES cell self-
renewal. Treated MEF cells yielded far 
fewer undifferentiated colonies than 
the NS cells, which passed all the tests 
of pluripotency: appropriate levels of 
ES cell marker expression; silencing of 
retroviral transgenes; gene expression 
from both X chromosomes; and 
the gold standard, healthy chimeric 
mice. Injecting 2i-iPS cells into mouse 
blastocysts generated live mice, 
indicating that the iPS cells had acted 
like normal ES cells to produce all the 
cell types that form a mouse, including 
the germ cells. 
Silva et al. go on to show that their 
2i cocktail induced transition to 
pluripotency, rather than selecting rare 
cells that had already reached that state 
by chance. Furthermore, NS cells could 
reach pluripotency with just two of the 
reprogramming factors, Oct4 and Klf4,
though with less efficiency.
This reprogramming approach 
produces cells in an undifferentiated 
but not pluripotent “pre-iPS” 
state—“poised on the threshold of 
pluripotency”—that can be stably 
maintained and propagated, then 
rapidly converted to pluripotency 
with a 2i/LIF elixir. This recipe may 
provide a final push by imposing what 
the researchers call a “ground state,” in 
which cells exist free of differentiation 
and epigenetic restrictions while 
retaining the ability to self-renew 
indefinitely. Because this technique 
requires fewer viral integrations, it may 
reduce the risk of cancer-promoting 
transgene integrations, a concern for 
using human iPS cells in regenerative 
medicine. And because it can yield 
abundant colonies of iPS cells with 
relative speed, it offers embattled 
stem cell researchers a flexible new 
technique for understanding one of 
biology’s most enduring mysteries: how 
pluripotent cells maintain the delicate 
balance between differentiation and 
immortality.
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